Aandeel TJBH TENGJUN BIOTECHNOLOGY CORP.
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren
Inactief instrument

Andere talen Tengjun Biotechnology Corp. Other OTC

Aandelen

TJBH

US88035C1071

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
Tengjun Biotechnology Corp. Announces Chief Executive Officer Changes
Tengjun Biotechnology Corp. Announces Chief Financial Officer Changes
Tengjun Biotechnology Corp. Announces Board Changes
Tengjun Biotechnology : Change in Certifying Accountants - Form 8-K
Tengjun Biotechnology Corp. Announces CEO Changes
Tengjun Biotechnology Corp. Announces CFO Changes
Tengjun Biotechnology Corp. Announces Board Changes
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Tengjun Biotechnology Corp. (TJBH) on Behalf of Investors
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Tengjun Biotechnology Corp. Investors to Inquire About Securities Class Action Investigation – TJBH
Tengjun Biotechnology Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Tengjun Biotechnology : Non-Reliance on Previously Issued Financial Report - Form 8-K
Tengjun Biotechnology Corp. Resolves to Appoint Ms. Caihong Qu as the Interim Chief Executive Officer
Tengjun Biotechnology Corp. Resolves to Appoint Ms. Caihong Qu as Interim Chief Financial Officer
Tengjun Biotechnology Corp. Resolves to Appoint Ms. Caihong Qu as A Member of the Board
Tengjun Biotechnology Corp. Announces Demise of Xianchang Ma, Chief Executive Officer
Tengjun Biotechnology Corp. Announces Xianchang Ma, Chief Financial Officer, Passed Away
Tengjun Biotechnology Corp. Announces demise of Xianchang Ma, Director
Tengjun Biotechnology Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023
TENGJUN BIOTECHNOLOGY CORP. : Other Events (form 8-K)
TENGJUN BIOTECHNOLOGY CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers TJBH
  4. Koers TJBH
  5. Nieuws Tengjun Biotechnology Corp.
  6. Andere talen